2023-02-012024-01-312024-01-31false10568101DNA ESCAPE LIMITED2024-10-1782990iso4217:GBPxbrli:pure105681012023-02-01105681012024-01-31105681012023-02-012024-01-31105681012022-02-01105681012023-01-31105681012022-02-012023-01-3110568101bus:SmallEntities2023-02-012024-01-3110568101bus:AuditExempt-NoAccountantsReport2023-02-012024-01-3110568101bus:FullAccounts2023-02-012024-01-3110568101bus:PrivateLimitedCompanyLtd2023-02-012024-01-3110568101core:WithinOneYear2024-01-3110568101core:AfterOneYear2024-01-3110568101core:WithinOneYear2023-01-3110568101core:AfterOneYear2023-01-3110568101core:ShareCapital2024-01-3110568101core:SharePremium2024-01-3110568101core:RevaluationReserve2024-01-3110568101core:OtherReservesSubtotal2024-01-3110568101core:RetainedEarningsAccumulatedLosses2024-01-3110568101core:ShareCapital2023-01-3110568101core:SharePremium2023-01-3110568101core:RevaluationReserve2023-01-3110568101core:OtherReservesSubtotal2023-01-3110568101core:RetainedEarningsAccumulatedLosses2023-01-3110568101core:LandBuildings2024-01-3110568101core:PlantMachinery2024-01-3110568101core:Vehicles2024-01-3110568101core:FurnitureFittings2024-01-3110568101core:OfficeEquipment2024-01-3110568101core:NetGoodwill2024-01-3110568101core:IntangibleAssetsOtherThanGoodwill2024-01-3110568101core:ListedExchangeTraded2024-01-3110568101core:UnlistedNon-exchangeTraded2024-01-3110568101core:LandBuildings2023-01-3110568101core:PlantMachinery2023-01-3110568101core:Vehicles2023-01-3110568101core:FurnitureFittings2023-01-3110568101core:OfficeEquipment2023-01-3110568101core:NetGoodwill2023-01-3110568101core:IntangibleAssetsOtherThanGoodwill2023-01-3110568101core:ListedExchangeTraded2023-01-3110568101core:UnlistedNon-exchangeTraded2023-01-3110568101core:LandBuildings2023-02-012024-01-3110568101core:PlantMachinery2023-02-012024-01-3110568101core:Vehicles2023-02-012024-01-3110568101core:FurnitureFittings2023-02-012024-01-3110568101core:OfficeEquipment2023-02-012024-01-3110568101core:NetGoodwill2023-02-012024-01-3110568101core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3110568101core:ListedExchangeTraded2023-02-012024-01-3110568101core:UnlistedNon-exchangeTraded2023-02-012024-01-3110568101core:MoreThanFiveYears2023-02-012024-01-3110568101core:Non-currentFinancialInstruments2024-01-3110568101core:Non-currentFinancialInstruments2023-01-3110568101dpl:CostSales2023-02-012024-01-3110568101dpl:DistributionCosts2023-02-012024-01-3110568101core:LandBuildings2023-02-012024-01-3110568101core:PlantMachinery2023-02-012024-01-3110568101core:Vehicles2023-02-012024-01-3110568101core:FurnitureFittings2023-02-012024-01-3110568101core:OfficeEquipment2023-02-012024-01-3110568101dpl:AdministrativeExpenses2023-02-012024-01-3110568101core:NetGoodwill2023-02-012024-01-3110568101core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3110568101dpl:GroupUndertakings2023-02-012024-01-3110568101dpl:ParticipatingInterests2023-02-012024-01-3110568101dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012024-01-3110568101core:ListedExchangeTraded2023-02-012024-01-3110568101dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012024-01-3110568101core:UnlistedNon-exchangeTraded2023-02-012024-01-3110568101dpl:CostSales2022-02-012023-01-3110568101dpl:DistributionCosts2022-02-012023-01-3110568101core:LandBuildings2022-02-012023-01-3110568101core:PlantMachinery2022-02-012023-01-3110568101core:Vehicles2022-02-012023-01-3110568101core:FurnitureFittings2022-02-012023-01-3110568101core:OfficeEquipment2022-02-012023-01-3110568101dpl:AdministrativeExpenses2022-02-012023-01-3110568101core:NetGoodwill2022-02-012023-01-3110568101core:IntangibleAssetsOtherThanGoodwill2022-02-012023-01-3110568101dpl:GroupUndertakings2022-02-012023-01-3110568101dpl:ParticipatingInterests2022-02-012023-01-3110568101dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-012023-01-3110568101core:ListedExchangeTraded2022-02-012023-01-3110568101dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-012023-01-3110568101core:UnlistedNon-exchangeTraded2022-02-012023-01-3110568101core:NetGoodwill2024-01-3110568101core:IntangibleAssetsOtherThanGoodwill2024-01-3110568101core:LandBuildings2024-01-3110568101core:PlantMachinery2024-01-3110568101core:Vehicles2024-01-3110568101core:FurnitureFittings2024-01-3110568101core:OfficeEquipment2024-01-3110568101core:AfterOneYear2024-01-3110568101core:WithinOneYear2024-01-3110568101core:ListedExchangeTraded2024-01-3110568101core:UnlistedNon-exchangeTraded2024-01-3110568101core:ShareCapital2024-01-3110568101core:SharePremium2024-01-3110568101core:RevaluationReserve2024-01-3110568101core:OtherReservesSubtotal2024-01-3110568101core:RetainedEarningsAccumulatedLosses2024-01-3110568101core:NetGoodwill2023-01-3110568101core:IntangibleAssetsOtherThanGoodwill2023-01-3110568101core:LandBuildings2023-01-3110568101core:PlantMachinery2023-01-3110568101core:Vehicles2023-01-3110568101core:FurnitureFittings2023-01-3110568101core:OfficeEquipment2023-01-3110568101core:AfterOneYear2023-01-3110568101core:WithinOneYear2023-01-3110568101core:ListedExchangeTraded2023-01-3110568101core:UnlistedNon-exchangeTraded2023-01-3110568101core:ShareCapital2023-01-3110568101core:SharePremium2023-01-3110568101core:RevaluationReserve2023-01-3110568101core:OtherReservesSubtotal2023-01-3110568101core:RetainedEarningsAccumulatedLosses2023-01-3110568101core:NetGoodwill2022-02-0110568101core:IntangibleAssetsOtherThanGoodwill2022-02-0110568101core:LandBuildings2022-02-0110568101core:PlantMachinery2022-02-0110568101core:Vehicles2022-02-0110568101core:FurnitureFittings2022-02-0110568101core:OfficeEquipment2022-02-0110568101core:AfterOneYear2022-02-0110568101core:WithinOneYear2022-02-0110568101core:ListedExchangeTraded2022-02-0110568101core:UnlistedNon-exchangeTraded2022-02-0110568101core:ShareCapital2022-02-0110568101core:SharePremium2022-02-0110568101core:RevaluationReserve2022-02-0110568101core:OtherReservesSubtotal2022-02-0110568101core:RetainedEarningsAccumulatedLosses2022-02-0110568101core:AfterOneYear2023-02-012024-01-3110568101core:WithinOneYear2023-02-012024-01-3110568101core:Non-currentFinancialInstrumentscore:CostValuation2023-02-012024-01-3110568101core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-012024-01-3110568101core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-012024-01-3110568101core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-012024-01-3110568101core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-012024-01-3110568101core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-012024-01-3110568101core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3110568101core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3110568101core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3110568101core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3110568101core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3110568101core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3110568101core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3110568101core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3110568101core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3110568101core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3110568101core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3110568101core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3110568101core:Non-currentFinancialInstrumentscore:CostValuation2023-01-3110568101core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-3110568101core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-3110568101core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-3110568101core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-3110568101core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-3110568101core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-3110568101core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-3110568101core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-3110568101bus:Director12023-02-012024-01-3110568101bus:Director22023-02-012024-01-3110568101bus:Director32023-02-012024-01-3110568101core:FurnitureFittingsToolsEquipment2023-01-3110568101core:FurnitureFittingsToolsEquipment2023-02-012024-01-3110568101core:FurnitureFittingsToolsEquipment2024-01-31

DNA ESCAPE LIMITED

Registered Number
10568101
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2024

DNA ESCAPE LIMITED
Company Information
for the year from 1 February 2023 to 31 January 2024

Directors

MONOGAROV, Denis
TSYURUPA, Alexander
TSYURUPA, Anastasia

Registered Address

C/O Clearstone Business Services The Dock Hub
Wilbury Villas
Hove
BN3 6AH

Registered Number

10568101 (England and Wales)
DNA ESCAPE LIMITED
Balance Sheet as at
31 January 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets397,88366,128
Tangible assets4503,378568,686
601,261634,814
Current assets
Debtors111,159120,412
Cash at bank and on hand23,860183,546
135,019303,958
Creditors amounts falling due within one year5(195,064)(80,613)
Net current assets (liabilities)(60,045)223,345
Total assets less current liabilities541,216858,159
Creditors amounts falling due after one year6(967,542)(897,315)
Net assets(426,326)(39,156)
Capital and reserves
Called up share capital150,143150,143
Profit and loss account(576,469)(189,299)
Shareholders' funds(426,326)(39,156)
The financial statements were approved and authorised for issue by the Board of Directors on 17 October 2024, and are signed on its behalf by:
TSYURUPA, Alexander
Director
Registered Company No. 10568101
DNA ESCAPE LIMITED
Notes to the Financial Statements
for the year ended 31 January 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
2.Average number of employees

20242023
Average number of employees during the year4560
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 February 2396,14596,145
Additions63,16463,164
At 31 January 24159,309159,309
Amortisation and impairment
At 01 February 2330,01730,017
Charge for year31,40931,409
At 31 January 2461,42661,426
Net book value
At 31 January 2497,88397,883
At 31 January 2366,12866,128
4.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 February 23463,320136,048207,566806,934
Additions(46,412)19,52229,5292,639
At 31 January 24416,908155,570237,095809,573
Depreciation and impairment
At 01 February 23-100,365137,883238,248
Charge for year-25,17042,77767,947
At 31 January 24-125,535180,660306,195
Net book value
At 31 January 24416,90830,03556,435503,378
At 31 January 23463,32035,68369,683568,686
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables93,75938,546
Bank borrowings and overdrafts10,2423,360
Taxation and social security89,76338,707
Accrued liabilities and deferred income1,300-
Total195,06480,613
6.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts98,64391,365
Other creditors868,899805,950
Total967,542897,315